Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges.

TL;DR: The aim of the workshops were to highlight some of the most controversial aspects of current knowledge on MRONJ, including definition and classification, risk factors and management and provide an expert opinion-based consensus with a view to inform clinicians and advise researchers, as a first step of reaching solutions.

Abstract: This paper reports on the conclusions of two workshops held in Copenhagen in September 2017 and November 2018 focused on medication-related osteonecrosis of the jaws (MRONJ). The workshops were organized and attended by a European task force on MRONJ, i.e. a multidisciplinary group of European clinical investigators with a special interest in the diagnosis and management of MRONJ and a track record of relevant research and publications. The aim of the workshops were to (i) highlight some of the most controversial aspects of current knowledge on MRONJ, including definition and classification, risk factors and management, and (ii) provide an expert opinion-based consensus with a view to inform clinicians and advise researchers, as a first step of reaching solutions. It should be pointed out that all results and comments presented are the authors (the workshop group members) personal views and the present form of this publication is based on genuine consensus of all authors. This article is protected by copyright. All rights reserved.